The Sonia Elijah Podcast · Investigative journalism, forensic style

🚩Call To Halt The COVID-19 mRNA Shots

·56 min·3 clips

Maria says Kevin McKernan found SV40 promoter-enhancer DNA with an origin of replication in Pfizer vials.

1. The Sonia Elijah Podcast episode “🚩Call To Halt The COVID-19 mRNA Shots” centers on Maria Gucci’s criticism of the COVID-19 mRNA authorization record and the resulting Canadian regulatory concerns. 2. Maria Gucci is a pharmacist trained at Wayne State University who says she spent years in hospital pharmacy, infectious diseases, and Health Canada regulatory work. 3. The episode asks why the EMA EPARs, the vial data, and the Canadian FOIA record made her conclude that the manufacturing record needed closer scrutiny. 4. Maria says she first looked at the EMA’s published EPAR in February 2021 and found the report’s “specific obligations” unlike anything she had seen in 10 years of reading such documents. 5. She explains that specific obligations are legal requirements the sponsor must meet within a time period, while recommendations do not carry the same force. 6. Maria says the EMA EPARs were the most complete, detailed, and transparent regulatory summaries she used, compared with the Canadian and FDA documents she found more jumbled. 7. She says the pandemic reporting felt disjointed to her because, from her hospital infectious-disease background, the public narrative did not fit how she understood infectious diseases to work. 8. Maria describes the first red flags as manufacturing issues and says she told physicians that biologics require purity control because “the process is the product.” 9. She says the EMA identified five manufacturing obligations and that those problems were still present years later when she revisited the documents. 10. Maria says one major question was whether the product made the correct spike protein, and she ties that to the Blockgate issue and the Western blot size concerns. 11. She says BioNTech’s explanation was that the larger protein size was due to sugars, while the EMA asked for the testing to be repeated on several lots for consistency. 12. Maria also discusses ribosomal frame shifting, describing it as a code-shift in the ribosome that can change amino acid order and alter protein folding. 13. She says a 2023 Cambridge paper by Mulroney and colleagues reported this effect and that more empirical evidence is needed before the risk can be dismissed. 14. Maria connects that protein-processing discussion to the concern that small changes in amino acids can alter toxicity, efficacy, and the body’s immune recognition. 15. She says the vial testing showed DNA contamination, with qPCR meeting the WHO guideline of 10 nanograms per dose but fluorometry showing much more DNA than expected. 16. Maria says Moderna had more smaller fragments and more total DNA than Pfizer, while Pfizer had bigger pieces and more lot-to-lot variability. 17. She describes the SV40 finding as a 350-base-pair fragment containing a promoter, enhancer, and origin of replication, and says those features raise serious regulatory questions. 18. Maria says Health Canada issued an issue analysis summary and asked Pfizer for a 56-page justification report, but much of it remains redacted in the FOIA record. 19. The interview is a technical, adversarial discussion with repeated clarifications, and Maria often shifts into plain-language analogies such as a “Trojan horse” for lipid nanoparticles. 20. People interested in vaccine manufacturing, regulatory filings, and Canadian FOIA records would likely listen, while listeners wanting a general COVID overview would probably skip it.

As heard by us

A document-first critique that moves from EMA paperwork to contamination concerns and unresolved protein-level questions.

Maria Gucci, trained as a pharmacist and later active in government and regulatory work tied to Health Canada, is most convincing when she traces the sequence step by step: the pandemic, the EMA paperwork, and then the DNA contamination questions.

Read the full review in PlayNext →

Why you'd press play

If you want a pharmacist's regulatory critique of COVID-19 mRNA shots, laid out through documents, methods, and a careful read of what the record does and does not show.

Read the full recommendation in PlayNext →

Listen to the show on

Apple Podcasts Spotify

Play clips from this episode More from The Sonia Elijah Podcast